Literature DB >> 17259383

Haplotypes of transcription factor 7-like 2 (TCF7L2) gene and its upstream region are associated with type 2 diabetes and age of onset in Mexican Americans.

Donna M Lehman1, Kelly J Hunt, Robin J Leach, Jeanette Hamlington, Rector Arya, Hanna E Abboud, Ravindranath Duggirala, John Blangero, Harald H H Göring, Michael P Stern.   

Abstract

TCF7L2 acts as both a repressor and transactivator of genes, as directed by the Wnt signaling pathway. Recently, several highly correlated sequence variants located within a haplotype block of the TCF7L2 gene were observed to associate with type 2 diabetes in three Caucasian cohorts. We previously reported linkage of type 2 diabetes in the San Antonio Family Diabetes Study (SAFADS) cohort consisting of extended pedigrees of Mexican Americans to the region of chromosome 10q harboring TCF7L2. We therefore genotyped 11 single nucleotide polymorphisms (SNPs) from nine haplotype blocks across the gene in 545 SAFADS subjects (178 diabetic) to investigate their role in diabetes pathogenesis. We observed nominal association between four SNPs (rs10885390, rs7903146, rs12255372, and rs3814573) in three haplotype blocks and type 2 diabetes, age at diagnosis, and 2-h glucose levels (P = 0.001-0.055). Furthermore, we identified a common protective haplotype defined by these four SNPs that was significantly associated with type 2 diabetes and age at diagnosis (P = 4.2 x 10(-5), relative risk [RR] 0.69; P = 6.7 x 10(-6), respectively) and a haplotype that confers diabetes risk that contains the rare alleles at SNPs rs10885390 and rs12255372 (P = 0.02, RR 1.64). These data provide evidence that variation in the TCF7L2 genomic region may affect risk for type 2 diabetes in Mexican Americans, but the attributable risk may be lower than in Caucasian populations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17259383     DOI: 10.2337/db06-0860

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  53 in total

1.  Prime suspect: the TCF7L2 gene and type 2 diabetes risk.

Authors:  Andrew T Hattersley
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

Review 2.  Wnt/beta-catenin signaling in adipogenesis and metabolism.

Authors:  Tyler C Prestwich; Ormond A Macdougald
Journal:  Curr Opin Cell Biol       Date:  2007-11-09       Impact factor: 8.382

Review 3.  The Wnt signaling pathway: aging gracefully as a protectionist?

Authors:  Kenneth Maiese; Faqi Li; Zhao Zhong Chong; Yan Chen Shang
Journal:  Pharmacol Ther       Date:  2008-02-11       Impact factor: 12.310

4.  Association of common genetic variants with diabetes and metabolic syndrome related traits in the Arizona Insulin Resistance registry: a focus on Mexican American families in the Southwest.

Authors:  Jacob DeMenna; Sobha Puppala; Geetha Chittoor; Jennifer Schneider; Joon Young Kim; Gabriel Q Shaibi; Lawrence J Mandarino; Ravindranath Duggirala; Dawn K Coletta
Journal:  Hum Hered       Date:  2014-07-08       Impact factor: 0.444

5.  Impact of TCF7L2 single nucleotide polymorphisms on hydrochlorothiazide-induced diabetes.

Authors:  Jason H Karnes; Yan Gong; Michael A Pacanowski; Caitrin W McDonough; Meghan J Arwood; Taimour Y Langaee; Carl J Pepine; Julie A Johnson; Rhonda M Cooper-Dehoff
Journal:  Pharmacogenet Genomics       Date:  2013-12       Impact factor: 2.089

Review 6.  Novel directions for diabetes mellitus drug discovery.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Shaohui Wang
Journal:  Expert Opin Drug Discov       Date:  2012-10-24       Impact factor: 6.098

Review 7.  Human QTL linkage mapping.

Authors:  Laura Almasy; John Blangero
Journal:  Genetica       Date:  2008-07-31       Impact factor: 1.082

Review 8.  Triple play: promoting neurovascular longevity with nicotinamide, WNT, and erythropoietin in diabetes mellitus.

Authors:  Kenneth Maiese
Journal:  Biomed Pharmacother       Date:  2008-02-20       Impact factor: 6.529

9.  TCF7L2 variant genotypes and type 2 diabetes risk in Brazil: significant association, but not a significant tool for risk stratification in the general population.

Authors:  G F Marquezine; A C Pereira; A G P Sousa; J G Mill; W A Hueb; J E Krieger
Journal:  BMC Med Genet       Date:  2008-12-04       Impact factor: 2.103

Review 10.  Erythropoietin, forkhead proteins, and oxidative injury: biomarkers and biology.

Authors:  Kenneth Maiese; Jinling Hou; Zhao Zhong Chong; Yan Chen Shang
Journal:  ScientificWorldJournal       Date:  2009-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.